We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sublocade modified release solution for injection Indivior Pty Ltd
Product name
Sublocade modified release solution for injection
Sponsor
Accepted date
Jan-2025
Active ingredients
buprenorphine
Proposed indication
SUBLOCADE is for the treatment of opioid dependence, in parallel with other medical, social and psychological treatment.
Application type
C (new indication)
Publication date
Jan-2025